Skip to main content

WatchPAT vs ApneaLink vs Night Owl: Home Sleep Test Devices Compared

Date Published

WatchPAT vs ApneaLink vs Night Owl Home Sleep Test Devices Compared

Three FDA-approved home sleep test devices, three different ways of measuring apnea. Here's an honest comparison from a provider that uses all three — and how we choose which one to send each patient.

Quick answer: All three devices are FDA-approved and clinically accepted for diagnosing obstructive sleep apnea in adults. ApneaLink (ResMed) uses direct airflow measurement and is closest to in-lab methodology. WatchPAT (Itamar) uses peripheral arterial tonometry, a finger probe, and skips the nasal cannula. Night Owl (Ectosense) is a single finger sensor with smartphone upload, ideal for travelers.

The three home sleep test devices in widest clinical use in the United States are the WatchPAT, the ApneaLink Air, and the Night Owl. All three are FDA-approved. All three are accepted by major insurance carriers. They differ in what they measure and which patients they handle best, and we use all three at SleepDr depending on what the chart looks like.

ZapZzz markets WatchPAT exclusively. Other providers favor ApneaLink. We don't have an exclusive vendor relationship with any of them, which is why we can compare honestly. Here's what each does and which patients we typically send each one to.

How do home sleep test devices work?

All three estimate the apnea-hypopnea index (AHI), the standard metric your sleep physician uses to diagnose OSA, from a small set of physiologic signals. Some measure airflow directly. Others infer it from autonomic nervous system changes. The output is the same number; the methodology differs.

WatchPAT (Itamar Medical)

WatchPAT uses peripheral arterial tonometry, a finger probe that picks up changes in arterial tone, plus a chest sensor for body position and snoring, plus a pulse oximeter. It infers apnea events from autonomic signals rather than directly measuring airflow.

  • Best for: patients with chronic nasal congestion or who can't tolerate a nasal cannula
  • Pros: simple to apply, no cannula, includes REM detection via the PAT signal
  • Cons: indirect airflow measurement, less reliable in patients on alpha-blockers
  • Typical study: 1 night, 4+ hours of recording required

ApneaLink Air uses a nasal cannula for airflow, a chest belt for breathing effort, and a finger pulse oximeter. It directly measures the same channels polysomnography measures (minus EEG), making it the home test that most resembles in-lab methodology.

  • Best for: cases where direct airflow measurement matters, including borderline OSA
  • Pros: direct airflow and effort measurement, closest HSAT methodology to PSG
  • Cons: cannula can be uncomfortable for patients with chronic congestion; more sensors to apply
  • Typical study: 1–2 nights, 4+ hours of recording required

Night Owl (Ectosense)

Night Owl is the smallest of the three, a single finger sensor, no chest belt, no cannula. It measures peripheral oxygen, heart rate, and movement, and pairs with a smartphone app that handles upload. It's the device drivers and travelers love because there's almost nothing to set up.

  • Best for: travelers, drivers in active layover, patients who failed a prior multi-sensor test
  • Pros: minimal setup, very high first-attempt success rate, multiple consecutive nights of data
  • Cons: fewer channels means slightly lower sensitivity for mild OSA
  • Typical study: 2–3 consecutive nights, smartphone-driven workflow

How do we decide which device to send?

Device selection is part of the provider workup, not a sales decision. We match the device to the patient based on what the ordering physician sees in the chart:

  • Chronic nasal congestion or deviated septum: WatchPAT or Night Owl (skip the cannula)
  • Borderline pretest probability where direct airflow matters: ApneaLink
  • CDL driver in active rotation: Night Owl (multi-night, smartphone-based, fits in a duffel)
  • Patient who failed a prior cannula-based test: WatchPAT or Night Owl
  • Patient on alpha-blockers or with autonomic neuropathy: ApneaLink (PAT signal isn't reliable here)

All three devices produce a report that the same board-certified sleep physician reads, and all three bill under the same Medicare and commercial plan codes. The end clinical decision, do you have OSA, and how severe, is independent of which device captured the data.

Frequently asked questions

For uncomplicated obstructive sleep apnea, all three are clinically accepted and produce equivalent diagnostic conclusions in the AASM-defined target population. ApneaLink's methodology is closest to in-lab polysomnography. WatchPAT and Night Owl trade a couple of channels for patient comfort and ease of use.

You can — and we'll accommodate when it's clinically appropriate. If you've got a strong reason (a prior failed test, chronic congestion, or you're traveling during the test window), let us know during scheduling.

If the recording fails to capture the minimum required hours, we re-issue a device at no additional charge. Our first-attempt success rate across all three devices is above 95%.

CPT 95800 covers home sleep tests with type III recording (airflow, effort, oximetry, heart rate). HCPCS G0398 is the Medicare equivalent. ApneaLink and most WatchPAT configurations bill under 95800; Night Owl studies, depending on configuration, may bill 95801. We verify coverage before shipping any device.

Ready When You Are

Take a home sleep test in California

FDA-approved devices delivered to your door. Board-certified physicians review your results. 100+ insurance plans accepted.